|
>Laboratory Research
Concentration |
Qing Song's Research
Laboratory The imminent completion of the Human Genome Project (HGP)
provides an unprecedented opportunity to begin to define novel genetic
variants that predispose to complex traits. The longstanding interest
of Dr. Song's research laboratory is to understand the molecular mechanisms
of genetic susceptibility to the cardiovascular disease, obesity and
diabetes. One of the major objectives is to define the role of genetic
variants in the gene regulation and the pathogenesis of atherosclerosis.
Our laboratory is currently employing the technologies of Denaturing
high performance liquid chromatography (DHPLC), Pyrosequencing, DNA
microarray and bioinformatics, as well as those classical molecular
biology and cell biology techniques. In addition, as a joint function
of molecular genetics in the Clinical Research Center of the Morehouse
School of Medicine, Dr. Song's laboratory is actively involved in the
population genetic epidemiological studies of hypertension, atherosclerosis,
and endothelial dysfunction. Current Research Project Funding Awards: VA Maryland Health Care System
Research Service Funding from National Institutes
of Health National Center for Research Resources |